Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity (Q28373048)

Annals of Pharmacotherapy

Europe PubMed Central

title

Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity (English)

0 references

0 references

0 references

0 references

1 reference

C A Luque

1

0 references

J A Rey

series ordinal

2

0 references

language of work or name

English

0 references

publication date

September 1999

0 references

published in

0 references

volume

33

0 references

issue

9

0 references

page(s)

968-78

0 references

cites work

Medical hazards of obesity

1 reference

Valvular heart disease associated with fenfluramine-phentermine

21 January 2018

1 reference

Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence

21 January 2018

1 reference

The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation.

21 January 2018

1 reference

Clinical pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant, in healthy volunteers

21 January 2018

1 reference

[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.

21 January 2018

1 reference

A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine

21 January 2018

1 reference

The effects of BTS 54,505, a metabolite of sibutramine, on monoamine and excitatory amino acid-evoked responses in the rat dorsolateral geniculate nucleus in vivo

21 January 2018

1 reference

A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents

21 January 2018

1 reference

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

21 January 2018

1 reference

Appetite suppressants. A review

21 January 2018

1 reference

Dexfenfluramine. A review of its pharmacological properties and therapeutic potential in obesity

21 January 2018

1 reference

The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride

21 January 2018

1 reference

Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat

21 January 2018

1 reference

Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat.

21 January 2018

1 reference

A comparison of various antidepressant drugs demonstrates rapid desensitisation of alpha 2-adrenoceptors exclusively by sibutramine hydrochloride.

21 January 2018

1 reference

Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants

21 January 2018

1 reference

Characterization of P1-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae

21 January 2018

1 reference

Effects of sibutramine on resting metabolic rate and weight loss in overweight women

21 January 2018

1 reference

Sibutramine pharmacokinetics in young and elderly healthy subjects.

21 January 2018

1 reference

Sibutramine in weight control: a dose-ranging, efficacy study

21 January 2018

1 reference

Sibutramine produces dose-related weight loss

21 January 2018

1 reference

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

21 January 2018

1 reference

Sibutramine: a new weight loss agent without evidence of the abuse potential associated with amphetamines

21 January 2018

1 reference

Overweight and obesity in the United States: prevalence and trends, 1960-1994

21 January 2018

1 reference

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults

21 January 2018

1 reference

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

21 January 2018

1 reference

The cost of obesity: the US perspective

21 January 2018

1 reference

Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine

21 January 2018

1 reference

Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl

21 January 2018

1 reference

[3H]nisoxetine--a radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments

21 January 2018

1 reference

D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function

21 January 2018

1 reference

Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic α2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride

21 January 2018

1 reference

Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex

21 January 2018

1 reference

Sibutramine reduces food intake in non-dieting women with obesity

21 January 2018

1 reference

Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

21 January 2018

1 reference

A double-blind randomized placebo-controlled trial of sibutramine

21 January 2018

1 reference

A comparison of sibutramine and dexfenfluramine in the treatment of obesity

21 January 2018

1 reference